EvoNext Holdings SA (SWX:EVE)
Switzerland · Delayed Price · Currency is CHF 0.7740
-0.0060 (-0.77%)
Feb 6, 2026, 3:25 PM CET
EvoNext Holdings Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
78
Market Cap
5.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 9.44M | -6.10M | -39.27% |
| Dec 31, 2022 | 15.54M | 5.66M | 57.32% |
| Dec 31, 2021 | 9.88M | 2.34M | 30.99% |
| Dec 31, 2020 | 7.54M | -4.06M | -34.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Basilea Pharmaceutica AG | 236.21M |
| Idorsia | 232.51M |
| Newron Pharmaceuticals | 55.93M |
| Santhera Pharmaceuticals Holding AG | 49.02M |
| BioVersys AG | 1.31M |
| Xlife Sciences AG | 839.38K |
| Molecular Partners AG | 681.00K |
| Addex Therapeutics | 158.54K |